LSE:INDV - Indivior PLC Indivior PLC
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
Yahoo Finance
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2011 Q4 2012 Q4 2013 Q4 2014 Q1 2014 Q2 2014 Q3 2014 Q4 2015 Q1 2015 Q2 2015 Q3 2015 Q4 2016 Q1 2016 Q2 2016 Q3 2016 Q4 2017 Q1 2017 Q2 2017 Q3 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 724.86M
7.5%
753.03M
3.9%
791M
5.0%
818M
3.4%
838M
2.4%
882M
5.3%
901M
2.2%
947M
5.1%
1B
5.8%
1.04B
4.0%
1.09B
4.9%
1.12B
2.8%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 117.98M
11.3%
111M
-5.9%
127M
14.4%
132M
3.9%
140M
6.1%
154M
10.0%
159M
3.2%
161M
1.3%
173M
7.5%
179M
3.5%
186M
3.9%
193M
3.8%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 606.88M
6.8%
642.02M
5.8%
664M
3.4%
686M
3.3%
698M
1.7%
728M
4.3%
742M
1.9%
786M
5.9%
829M
5.5%
863M
4.1%
907M
5.1%
931M
2.6%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 585.89M
0.2%
799.03M
36.4%
610M
-23.7%
640M
4.9%
673M
5.2%
679M
0.9%
992M
46.1%
1.02B
2.9%
1.09B
6.7%
1.37B
25.9%
838M
-38.9%
1.12B
34.1%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 467.91M
-2.3%
688.02M
47.0%
483M
-29.8%
508M
5.2%
533M
4.9%
525M
-1.5%
833M
58.7%
860M
3.2%
916M
6.5%
1.19B
30.1%
652M
-45.3%
931M
42.8%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 138.97M
56.1%
-46M
-
181M
-
178M
-1.7%
165M
-7.3%
203M
23.0%
-91M
-
-74M
-
-87M
-
-329M
-
255M
-
0
-100%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 138.97M
54.4%
159.01M
14.4%
213M
34.0%
210M
-1.4%
200M
-4.8%
218M
9.0%
-85M
-
-82M
-
-84M
-
-323M
-
-4M
-
4M
-
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 138.97M
46.3%
156.01M
12.3%
205M
31.4%
166M
-19.0%
152M
-8.4%
166M
9.2%
-53M
-
-50M
-
-59M
-
-235M
-
2M
-
5M
150.0%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.95
46.1%
1.05
10.6%
1.4
33.3%
1.15
-17.9%
1.1
-4.3%
-4.1
-
-0.38
-
-0.27
-
-0.4
-
-1.69
-
0.01
-
0.04
300.0%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.9
38.4%
1
11.1%
1.35
35.0%
1.15
-14.8%
1.05
-8.7%
-4.15
-
-0.38
-
-0.35
-
-0.4
-
-1.69
-
0.01
-
0.04
300.0%
Values are in USD whenever applicable | Fiscal year ends on December 31
Powered by Morningstar

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms